Why is Thyrocare Tech. falling/rising?

As of 04-Aug, Thyrocare Technologies Ltd is experiencing a price increase, currently at 1,350.25, reflecting a rise of 29.45 or 2.23%. The stock has shown strong performance, with a 1-week return of 8.69% and a remarkable 33.56% increase over the past month, significantly outperforming the Sensex, which has declined by 2.89% in the same period. Today, the stock is trading close to its 52-week high, just 1.83% away, and has outperformed its sector by 3.45%. Additionally, it is trading above all key moving averages, indicating positive momentum. The company has demonstrated high management efficiency with a return on equity (ROE) of 20.45% and has reported a substantial net profit growth of 56.61%, contributing to its favorable market perception.
In the broader market context, Thyrocare's short-term performance stands in stark contrast to the Sensex, which has only gained 0.16% over the past week. The stock's strong returns over various periods, including a 66.52% increase over the last year, highlight its market-beating performance. However, there are risks to consider, such as the company's high valuation relative to its peers and the fact that 100% of promoter shares are pledged, which could exert downward pressure in adverse market conditions. Despite these risks, the overall positive financial results and strong investor participation are driving the stock's recent upward movement.